StonvexLoading…
StonvexStonvexStonvexCore line items from BALL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-09-30 | Annual 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $13.16B | $11.79B | $3.08B | $2.96B |
Operating Income | $1.13B | $535.00M | Not available | Not available |
Net Income | $915.00M | $4.01B | $199.00M | $159.00M |
EPS (Diluted) | $3.30 | $13.00 | $0.65 | $0.51 |
Total Assets | $19.52B | $17.63B | Not available | Not available |
Total Liabilities | $14.10B | $11.70B | Not available | Not available |
Cash & Equivalents | $1.21B | $885.00M | Not available | Not available |
Free Cash Flow OCF − CapEx | $788.00M | $-369.00M | Not available | Not available |
Shares Outstanding | 275.97M | 308.21M | Not available | Not available |